Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The study identified key immune cell differences between mild and severe alopecia areata.

New drug targets for hair loss treatment were identified by studying cell interactions in hair follicles.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Increased T cell activity may predict hair regrowth success with minoxidil in severe alopecia areata.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

DP cells interact with immune cells, possibly causing hair loss in Alopecia Areata.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Minoxidil may help hair regrowth in alopecia areata by affecting T-cells.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Belatacept may be a promising treatment for alopecia areata.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.